title: Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.
authors.affiliation: Department of Cardiology, Loyola University Medical Center, Maywood, Illinois 60153, USA. lcho@lumc.edu <lcho@lumc.edu>
authors.forename: Leslie
authors.initials: L
authors.lastname: Cho
authors.forename: Derek P
authors.initials: DP
authors.lastname: Chew
authors.forename: David J
authors.initials: DJ
authors.lastname: Moliterno
authors.forename: Marco
authors.initials: M
authors.lastname: Roffi
authors.forename: Stephen G
authors.initials: SG
authors.lastname: Ellis
authors.forename: Irving
authors.initials: I
authors.lastname: Franco
authors.forename: Christopher
authors.initials: C
authors.lastname: Bajzer
authors.forename: Deepak L
authors.initials: DL
authors.lastname: Bhatt
authors.forename: Khosrow
authors.initials: K
authors.lastname: Dorosti
authors.forename: Conrad
authors.initials: C
authors.lastname: Simpfendorder
authors.forename: Murat
authors.initials: M
authors.lastname: Tuzcu
authors.forename: Jay S
authors.initials: JS
authors.lastname: Yadav
authors.forename: Sorin
authors.initials: S
authors.lastname: Brener
authors.forename: Russell
authors.initials: R
authors.lastname: Raymond
authors.forename: Patrick
authors.initials: P
authors.lastname: Whitlow
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Topol
authors.forename: A Michael
authors.initials: AM
authors.lastname: Lincoff
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D019917:Blood Vessel Prosthesis Implantation; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006629:Hirudins / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010446:Peptide Fragments / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D015607:Stents; D015996:Survival Rate
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011994:Recombinant Proteins; C074619:bivalirudin